🔎 Trials Near Me

Beranda › HIV › Illinois › Chicago

Uji klinis HIV di Chicago, IL

14 studi untuk HIV mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

Menerima pesertaStudi observasional
  • DOM/Project WISH Research Clinic, Chicago
  • Rush University Medical Center/Division of Infectious Diseases, Chicago
  • Ruth M. Rothstein CORE Center, Chicago
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07473778

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Menerima pesertaFase 2/3
  • Rush University Medical Center-Infectious Disease ( Site 1522), Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07266831

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Menerima pesertaFase 1/2
  • 32515, Rush Univ./Cook County Hosp. Chicago CRS, Chicago
  • 4001, Lurie Children's Hospital of Chicago Clinical Research Site, Chicago
48 Hours · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT02140255

Dasatinib for HIV-1 Reservoir Reduction

Menerima pesertaFase 1
  • Northwestern University CRS (Site # 2701), Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07342491

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

Menerima pesertaFase 2
  • GSK Investigational Site, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07202546

The Trans-Led Care Study

Menerima peserta
  • Illinois Institute of Technology, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06880705

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Menerima pesertaFase 1
  • University of Illinois at Chicago, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05077527

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

Menerima peserta
  • Northwestern University, Chicago
  • Rush University Medical Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06263426

Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection

Menerima pesertaSukarelawan sehat diterima
  • Ali Keshavarzian, Chicago
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06139224

Menopausal HT for Women Living With HIV (HoT)

Menerima pesertaFase 4
  • Northwestern University CRS (2701), Chicago
Usia 40 hingga 60 · Wanita · Diperbarui 22 Mei 2026 · NCT06856174

Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men

Menerima pesertaSukarelawan sehat diterima
  • Northwestern University, Chicago
Usia 16 hingga 34 · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT05678556

IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)

Menerima pesertaSukarelawan sehat diterima
  • University of Illinois Chicago, Chicago
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT06266416

MyPEEPS LITE Trial

Menerima pesertaSukarelawan sehat diterima
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 16 hingga 29 · Pria · Diperbarui 27 Feb 2026 · NCT06741631

Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • John H. Stroger, Jr. Hospital of Cook County, Chicago
Usia 13 hingga 34 · Semua jenis kelamin · Diperbarui 8 Mei 2023 · NCT05848570

Uji klinis HIV di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.